In this system, the dendritic cells are activated and
targeted against tumor cells while remaining inside the patient's body.
Not exact matches
The Company focuses on discovering and developing small molecule drugs directed
against tumor and immune cell
targets that control key metabolic pathways in the
tumor microenvironment.
«Genes may cause
tumor aggressiveness, drug resistance in African - American prostate cancer: Research found many
targeted therapies for prostate cancer may not be effective
against tumors in African - American men.»
Drugs that
targeted the RAS pathway showed little activity
against the
tumor cells.
It is also a whole -
tumor vaccine, meant to stimulate an immune response
against not just one
tumor - associated
target but hundreds or thousands.
In their report that has received advance online publication in Nature Nanotechnology, a research team based at the Wellman Center for Photomedicine at Massachusetts General Hospital (MGH) describes how a nanomedicine that combines photodynamic therapy — the use of light to trigger a chemical reaction — with a molecular therapy drug
targeted against common treatment resistance pathways reduced a thousand-fold the dosage of the molecular therapy drug required to suppress
tumor progression and metastatic outgrowth in an animal model.
By tracking and understanding which host cell pathways are manipulated by these T. gondii proteins, scientists can identify potential new
targets to develop more effective therapies
against highly aggressive solid
tumors.
Because the vaccine causes the body to mount an immune response directed
against a unique
tumor, the therapy is much more effective than gene -
targeted or more general chemotherapy alone.
Another possibility that Irvine's lab is working on is developing treatments that could be used
against tumors even when scientists don't know of a specific vaccine
target for that type of
tumor.
«Novel imaging model helps reveal new therapeutic
target for pancreatic cancer: Antisense treatment in preclinical models shows effectiveness
against deadly
tumors.»
«If our findings are confirmed by additional studies, they may open doors to the development of
targeted therapies
against the
tumor subtypes more likely to affect African Americans and potentially help reduce racial disparities in breast cancer.»
Therapies based on immune cells, which
target particular
tumor molecules, are more specific, but they are not effective
against a variety of
tumors.
A T - cell marker panel that can identify subsets of
tumor - associated T - cells allows scientists to identify and
target subpopulations of T - cells playing unique roles in the immune response
against a
tumor.
'» In all patients who were vaccinated, his team found
tumor -
targeting T cells, and he noted that in addition to augmenting pre-existing T cell responses, the vaccine also stimulated new T cell responses
against tumors.
Our data suggests that
targeting DGKζ could prove to be a more useful clinical approach to augment cytotoxic T cell activity
against tumor than
targeting Cbl - b, perhaps resulting from enhanced Ras / ERK signaling.
At first, analyzing a patient's surgically removed
tumor and developing a vaccine
against 10 specific
targets on the
tumor took nine months, says Greg Lizée, Ph.D., associate professor of Melanoma Medical Oncology, whose research focuses on the immune system.
He said traditional drugs to treat tapeworm infection — which
target the whole organism at the larval stage - might not have been effective
against tapeworm cancer cells, and it's also unclear whether chemotherapy for normal human cancer cells could have helped shrink the
tumors.
Their work encompasses several strategies, including: developing FL - HCC animal models to characterize
tumor - immune interactions, exploring if a mutated protein associated with FL - HCC could be
targeted by immunotherapy, identifying immune checkpoints that could potentially serve as
targets for immunotherapy as well as biomarkers for analyzing patients, and evaluating the effectiveness of immunotherapy strategies
against FL - HCC patient samples in the lab.
Low - dose chemotherapy, radiation, or
targeted therapies given in combination with immune checkpoint blockade may prove to be an effective and efficient way to immunize the body
against tumor cells,» says CRI Scientific Advisory Council associate director James P. Allison, Ph.D., who identified the first immune checkpoint blockade with his discovery in 1995 that the cytotoxic T lymphocyte antigen - 4 (CTLA - 4) receptor inhibited T cell responses.
Researchers publish preclinical data suggesting the promise of a novel drug directed
against a novel
target n malignant mammary
tumors...
«We have created a potentially much less expensive approach to making a therapeutic cancer vaccine that, while
targeting a single
tumor antigen, generates an immune response
against multiple antigens.
Also, CMB305 was well tolerated, and generated a strong and broad anti-NY-ESO-1 immune response in > 50 % of the patients, including evidence of antigen spreading — the induction of an immune response
against other
tumor antigens not
targeted by CMB305.
Stephan's foggy early morning brainwave illuminated an unexpectedly simple approach to making cell - based immunotherapy, in which cancer -
targeting immune cells are enlisted to fight
tumor cells, as effective
against solid
tumors as it has been
against blood cancers like leukemia.
By exploiting these differences, scientists have developed therapies that
target specific
tumor types, and these
targeted therapies have proven useful
against most breast cancers.
«We're using the whole
tumor cell, and that allows us to stimulate a response that's broad, that's
against multiple
targets, and that's
against targets that are unique to that individual patient,» Avigan said.
The use of
targeting antibodies
against vascular endothelial growth factor (VEGF), a protein that promotes
tumor growth and spread, plus chemotherapy has prolonged disease free survival in several different
tumor types in man.